NOTE: this implementation guide uses STU3 resources. Therefore, the following FHIR 3.3.0 artifacts are only available for download or as raw xml in your browser.
NOTE: as of 3/18/2018, validation frameworks for FHIR 3.3.0 resources don't seem to be current. This has caused issues when trying to POST these artifacts to an FHIR 3.3.0 FHIR server.
The following FHIR 3.3.0 artifacts represent the behavior for implementing CDC Opioid Prescribing Guidelines:
| Resource | Type | Description |
|---|---|---|
| Risk Assessment for Opioid Use ActivityDefinition for Recommendation #7 (FHIR 3.3.0) | ActivityDefinition | Action rule that provides risk assessment suggestion for CDC Opioid Prescribing Guideline Recommendation #7 |
| CDC Opioid Prescribing Guideline Recommendation #4 (FHIR 3.3.0) | PlanDefinition | Event-Condition-Action rule that implements behavior for CDC Opioid Prescribing Guideline Recommendation #4 |
| CDC Opioid Prescribing Guideline Recommendation #5 (FHIR 3.3.0) | PlanDefinition | Event-Condition-Action rule that implements behavior for CDC Opioid Prescribing Guideline Recommendation #5 |
| CDC Opioid Prescribing Guideline Recommendation #7 (FHIR 3.3.0) | PlanDefinition | Event-Condition-Action rule that implements behavior for CDC Opioid Prescribing Guideline Recommendation #7 |
| CDC Opioid Prescribing Guideline Recommendation #8 (FHIR 3.3.0) | PlanDefinition | Event-Condition-Action rule that implements behavior for CDC Opioid Prescribing Guideline Recommendation #8 |
| CDC Opioid Prescribing Guideline Recommendation #10 (FHIR 3.3.0) | PlanDefinition | Event-Condition-Action rule that implements behavior for CDC Opioid Prescribing Guideline Recommendation #10 |
| CDC Opioid Prescribing Guideline Recommendation #11 (FHIR 3.3.0) | PlanDefinition | Event-Condition-Action rule that implements behavior for CDC Opioid Prescribing Guideline Recommendation #11 |
| Cardiology Order Set | PlanDefinition | The Cardiology chest pain (CP) and coronary artery disease (CAD) order set is intended to assist primary care providers in the management of adult patients with stable chest pain (with or without known CAD) |
| Common Opioid Decision Support FHIR 3.3.0 Logic | Library | FHIR 3.3.0 common logic for the recommendations |
| Common Opioid Decision Support FHIR 3.3.0 Logic | CQL Source | For reference, the complete CQL source for the common logic. |
| Common Opioid Decision Support FHIR 3.3.0 Logic | ELM Source | For reference, the complete ELM source for the common logic. |
| Recommendation #4 - prescribe immediate-release opioids instead of extended-release/long-acting (ER/LA) opioids | Library | Defines the data requirements to support evaluation of recommendation #4 |
| Recommendation #4 (FHIR 3.3.0) - prescribe immediate-release opioids instead of extended-release/long-acting (ER/LA) opioids | CQL Source | For reference, the complete CQL content for recommendation #4 |
| Recommendation #4 (FHIR 3.3.0) - prescribe immediate-release opioids instead of extended-release/long-acting (ER/LA) opioids | ELM Source | For reference, the complete ELM content for recommendation #4 |
| Recommendation #5 - lowest effective dosage | Library | Defines the data requirements to support evaluation of recommendation #5 |
| Recommendation #5 (FHIR 3.3.0) - lowest effective dosage | CQL Source | For reference, the complete CQL content for recommendation #5. |
| Recommendation #5 (FHIR 3.3.0) - lowest effective dosage | ELM Source | For reference, the complete ELM content for recommendation #5. |
| Recommendation #7 - benefits and harms of starting and/or continuing opioid therapy for chronic pain | Library | Defines the data requirements to support evaluation of recommendation #7 |
| Recommendation #7 (FHIR 3.3.0) - benefits and harms of starting and/or continuing opioid therapy for chronic pain | CQL Source | For reference, the complete CQL content for recommendation #7. |
| Recommendation #7 (FHIR 3.3.0) - benefits and harms of starting and/or continuing opioid therapy for chronic pain | ELM Source | For reference, the complete ELM content for recommendation #7. |
| Recommendation #8 - risk factors for opioid-related harms before and during opioid therapy | Library | Defines the data requirements to support evaluation of recommendation #8 |
| Recommendation #8 (FHIR 3.3.0) - risk factors for opioid-related harms before and during opioid therapy | CQL Source | For reference, the complete CQL source for recommendation #8 |
| Recommendation #8 (FHIR 3.3.0) - risk factors for opioid-related harms before and during opioid therapy | ELM Source | For reference, the complete ELM source for recommendation #8 |
| Recommendation #10 - urine drug testing when prescribing opioids for chronic pain | Library | Defines the data requirements to support evaluation of recommendation #10 |
| Recommendation #10 (FHIR 3.3.0) - urine drug testing when prescribing opioids for chronic pain | CQL Source | For reference, the complete CQL source for recommendation #10 |
| Recommendation #10 (FHIR 3.3.0) - urine drug testing when prescribing opioids for chronic pain | ELM Source | For reference, the complete ELM source for recommendation #10 |
| Recommendation #11 - concurrent opioid pain medication and benzodiazepines prescriptions | Library | Defines the data requirements to support evaluation of recommendation #11 |
| Recommendation #11 (FHIR 3.3.0) - concurrent opioid pain medication and benzodiazepines prescriptions | CQL Source | For reference, the complete CQL source for recommendation #11 |
| Recommendation #11 (FHIR 3.3.0) - concurrent opioid pain medication and benzodiazepines prescriptions | ELM Source | For reference, the complete ELM source for recommendation #11 |
© CDC 2016+. Opioid Prescribing Support Implementation Guide (v3.0.1-11917) generated on Thu, Feb 7, 2019 06:37+0000. QA Page
Links: Home |
Version History |
|
Propose a change 